Sellers’ departure leaves the Knight Cancer Institute with interim leaders in the top two positions. Interim CEO Dr. Shivanni ...

The website you are visiting is protected and accelerated by Imperva. Your computer may have been infected by malware and ...

The approval of a new breast cancer treatment has given hope to thousands of women with an incurable form of the disease.

A new study reveals that the protein alpha-synuclein, known for its role in Parkinson’s disease, also contributes to the ...

A small protein involved in neurodegeneration leading to Parkinson's disease also drives a type of skin cancer known as melanoma, according to new research.

A new drug that helps slow the spread of an incurable type of breast cancer has been approved for use in Britain's state-run ...

One of the world’s leading cancer researchers is stepping down as CEO of the Knight Cancer Institute at Oregon Health and Science University. Dr. Brian Druker handed in his resignation on ...

The Institute of Cancer Research, London (ICR ... and improve quality of life for patients wherever possible”. Helen Knight, director of medicines evaluation at Nice, said it had heard about ...

“The partnership between AstraZeneca, the Institute of Cancer Research ... drugs it had assessed in the last seven years. Helen Knight, director of medicines evaluation at Nice, said patients ...